Bioarray Genetic Diagnosis

Bioarray is a genetic testing provider, serving clinical partners in Europe, Latin America, MENA and Asia. Mainly using array CGH and NGS for: - Medical Genetics: WES, WGS - Reproductive Genetics: expanded carrier screening, preimplantation genetic testing (PGT), endometrial receptivity and prenatal diagnosis - Oncology: somatic and germline tests, liquid biopsy Bioarray is also a leading provider of research services, as gene expression studies based on array or RNA-seq. Bioarrays sister company Journey Genomics launched PGD-SeqTM, a kit for library preparation and data analysis, for easy PGT-M implementation for NGS labs

Clinical genetics,reproductive genetics,genomic research services,next generation sequencing,comparative genomic hybridation (cgh),whole exome sequencing,methylation analysis,microrna sequencing,dna microarrays,rna-seq,medical genetics,reproductive health,pgt,and carrier screening

Bioarray genetic diagnosis operates in the Medical and diagnostic laboratories industry.

Bioarray genetic diagnosis's revenue is 11m - 100m

Bioarray genetic diagnosis has 51 - 200 employees.